Candida Species by PCR
Also known as: CANDPCR
Use
The Candida Species by PCR test is utilized to detect and differentiate multiple Candida species directly in clinical specimens. This includes Candida albicans, C. glabrata, C. parapsilosis complex (C. parapsilosis, C. orthopsilosis, C. metapsilosis), C. tropicalis, C. krusei, and C. dubliniensis. Early and accurate identification of these species is crucial for guiding appropriate antifungal therapy and for infection control measures, due to the varying antifungal susceptibilities and pathogenicity among the different Candida species.
Special Instructions
Specimen source is required when submitting samples for testing. Ensure correct handling of specimens to avoid rejection due to unacceptable conditions. Different specimen types have specific storage and stability requirements that must be adhered to for accurate testing.
Limitations
A negative result does not exclude the presence of PCR inhibitors in the patient specimen or the presence of the test-specific nucleic acid at levels below the detection threshold. This test was developed and its performance characteristics determined by ARUP Laboratories: it has not been cleared or approved by the FDA, and results should be interpreted in conjunction with clinical findings.
New York Approved
Methodology
PCR-based (PCR)
Biomarkers
LOINC Codes
- 31208-2
- 101984-3
- 101987-6
- 101985-0
- 101988-4
- 101986-8
- 101989-2
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Body Fluid
Volume
1 mL
Minimum Volume
0.5 mL
Container
Sterile container
Collection Instructions
Transfer body fluid to a sterile container.
Storage Instructions
Keep frozen until transport.
Causes for Rejection
Specimen source required. Plasma or serum, tissues are unacceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 2 weeks |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant